AAAAAA
Results:
1-8
|
Results: 8
Authors:
KING DJ
LINK CGG
KOWALCYK B
Citation: Dj. King et al., A COMPARISON OF BD AND TID DOSE REGIMENS OF QUETIAPINE (SEROQUEL) IN THE TREATMENT OF SCHIZOPHRENIA, Psychopharmacology, 137(2), 1998, pp. 139-146
Authors:
SMALL JG
HIRSCH SR
ARVANITIS LA
MILLER BG
LINK CGG
MURPHY AL
BOWDEN CL
OBRIEN CP
STEINBOOK RM
WAGNER RL
PITTS WM
CRABTREE B
CORRIGAN MHN
LOHR JB
MILLER AL
ERESHEFSKY L
ANDERSON CB
KNESEVICH MA
ROTROSEN J
OWEN RR
KARSON CN
LINDENMAYER JP
PFEFFERBAUM A
FAUSTMAN WO
KECK PE
PATTERSON WM
RIESENBERG RA
GLADSON MB
KOLIN IS
BARNES TRE
SENSKY T
RICCIO M
FRANKS S
JOLLEY A
HALLSTROM C
BENNIE E
DARCOURT G
PATRIS M
DESILVA M
PATEL AG
FLEISCHHACKER WW
DIETZEL M
SEIFERTOVA D
VINAR O
FALTUS F
BITTER I
OZSVATH K
SHAW SH
MAHAPATRA SN
SZULECKA TK
SUNDARARAJAN K
CREAVEN F
LYNCH J
KLIESER E
COOPER SJ
ASCHAUER H
Citation: Jg. Small et al., QUETIAPINE IN PATIENTS WITH SCHIZOPHRENIA - A HIGH-DOSE AND LOW-DOSE DOUBLE-BLIND COMPARISON WITH PLACEBO, Archives of general psychiatry, 54(6), 1997, pp. 549-557
Authors:
PEUSKENS J
LINK CGG
Citation: J. Peuskens et Cgg. Link, A COMPARISON OF QUETIAPINE AND CHLORPROMAZINE IN THE TREATMENT OF SCHIZOPHRENIA, Acta psychiatrica Scandinavica, 96(4), 1997, pp. 265-273
THE ATYPICAL PROFILE OF ICI-204,636 IS SUPPORTED BY ITS LACK OF INDUCTION OF EXTRAPYRAMIDAL SYMPTOMS
Authors:
HONG WW
ARVANITIS LA
MILLER BG
LINK CGG
Citation: Ww. Hong et al., THE ATYPICAL PROFILE OF ICI-204,636 IS SUPPORTED BY ITS LACK OF INDUCTION OF EXTRAPYRAMIDAL SYMPTOMS, Psychopharmacology bulletin, 32(3), 1996, pp. 458-458
Authors:
HAMNER MB
ARVANITIS LA
MILLER BG
LINK CGG
HONG WW
Citation: Mb. Hamner et al., PLASMA PROLACTIN IN SCHIZOPHRENIA SUBJECTS TREATED WITH SEROQUEL(TM) (ICI-204,636), Psychopharmacology bulletin, 32(1), 1996, pp. 107-110
Authors:
HIRSCH SR
LINK CGG
GOLDSTEIN JM
ARVANITIS LA
Citation: Sr. Hirsch et al., ICI-204,636 - A NEW ATYPICAL ANTIPSYCHOTIC DRUG, British Journal of Psychiatry, 168, 1996, pp. 45-56
Authors:
ARVANITIS L
MILLER BG
LINK CGG
Citation: L. Arvanitis et al., SEROQUEL(TM) (ICI-204-636) - A NOVEL, ATYPICAL ANTIPSYCHOTIC - EFFICACY AND SAFETY RESULTS FROM 2 PHASE-II, MULTICENTER, PLACEBO-CONTROLLEDCLINICAL-TRIALS, Schizophrenia research, 15(1-2), 1995, pp. 142-142
Authors:
BORISON RL
ARVANITIS LA
MILLER BG
LINK CGG
HONG WW
Citation: Rl. Borison et al., SEROQUEL (ICI-204,636) - A NOVEL, ATYPICAL ANTIPSYCHOTIC, Biological psychiatry, 37(9), 1995, pp. 661-661
Risultati:
1-8
|